Idorsia Ltd (SWX:IDIA)
Switzerland · Delayed Price · Currency is CHF 4.584
+0.310 (7.25%)
May 13, 2026, 5:31 PM CET
Idorsia Market Cap
Idorsia has a market cap or net worth of 1.09 billion as of May 13, 2026. Its market cap has increased by 363.04% in one year.
Market Cap
1.09B
Enterprise Value
2.27B
Revenue
220.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.58
Market Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.63B to 1.09B, a decrease of -32.96%. That is a compound annual growth rate of -4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 1.09B | 2.57% |
| Dec 30, 2025 | 1.06B | 586.49% |
| Dec 30, 2024 | 154.81M | -58.92% |
| Dec 29, 2023 | 376.84M | -84.18% |
| Dec 30, 2022 | 2.38B | -27.77% |
| Dec 30, 2021 | 3.30B | -22.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.79B |
| Basilea Pharmaceutica AG | 684.64M |
| Newron Pharmaceuticals | 283.01M |
| Santhera Pharmaceuticals Holding AG | 241.01M |
| BioVersys AG | 157.31M |
| Xlife Sciences AG | 121.12M |
| Molecular Partners AG | 118.97M |
| MindMaze Therapeutics Holding | 56.92M |